TY - JOUR
T1 - Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide
T2 - Molecular dynamics simulations of HLA-A*0217
AU - Toh, Hidehiro
AU - Savoie, Christopher J.
AU - Kamikawaji, Nobuhiro
AU - Muta, Shigeru
AU - Sasazuki, Takehiko
AU - Kuhara, Satoru
PY - 2000/10/15
Y1 - 2000/10/15
N2 - We report on molecular dynamics simulations of major histocompatibility complex (MHC)-peptide complexes. Class I MHC molecules play an important role in cellular immunity by presenting antigenic peptides to cytotoxic T cells. Pockets in the peptide-binding groove of MHC molecules accommodate anchor side chains of the bound peptide. Amino acid substitutions in MHC affect differences in the peptide-anchor motifs. HLA-A*0217, human MHC class I molecule, differs from HLA-A*0201 only by three amino acid residues substitutions (positions 95, 97, and 99) at the floor of the peptide-binding groove. A*0217 showed a strong preference for Pro at position 3 (p3) and accepted Phe at p9 of its peptide ligands, but these preferences have not been found in other HLA-A2 ligands. To reveal the structural mechanism of these observations, the A*0217-peptide complexes were simulated by 1000 ps molecular dynamics at 300 K with explicit solvent molecules and compared with those of the A*0201-peptide complexes. We examined the distances between the anchor side chain of the bound peptide and the pocket, and the rms fluctuations of the bound peptides and the HLA molecules. On the basis of the results from our simulations, we propose that Pro at p3 serves as an optimum residue to lock the dominant anchor residue (p9) tightly into pocket F and to hold the peptide in the binding groove, rather than a secondary anchor residue fitting optimally the complementary pocket. We also found that Phe at p9 is used to occupy the space created by replacements of three amino acid residues at the floor within the groove. These findings would provide a novel understanding in the peptide-binding motifs of class I MHC molecules. (C) 2000 John Wiley and Sons, Inc.
AB - We report on molecular dynamics simulations of major histocompatibility complex (MHC)-peptide complexes. Class I MHC molecules play an important role in cellular immunity by presenting antigenic peptides to cytotoxic T cells. Pockets in the peptide-binding groove of MHC molecules accommodate anchor side chains of the bound peptide. Amino acid substitutions in MHC affect differences in the peptide-anchor motifs. HLA-A*0217, human MHC class I molecule, differs from HLA-A*0201 only by three amino acid residues substitutions (positions 95, 97, and 99) at the floor of the peptide-binding groove. A*0217 showed a strong preference for Pro at position 3 (p3) and accepted Phe at p9 of its peptide ligands, but these preferences have not been found in other HLA-A2 ligands. To reveal the structural mechanism of these observations, the A*0217-peptide complexes were simulated by 1000 ps molecular dynamics at 300 K with explicit solvent molecules and compared with those of the A*0201-peptide complexes. We examined the distances between the anchor side chain of the bound peptide and the pocket, and the rms fluctuations of the bound peptides and the HLA molecules. On the basis of the results from our simulations, we propose that Pro at p3 serves as an optimum residue to lock the dominant anchor residue (p9) tightly into pocket F and to hold the peptide in the binding groove, rather than a secondary anchor residue fitting optimally the complementary pocket. We also found that Phe at p9 is used to occupy the space created by replacements of three amino acid residues at the floor within the groove. These findings would provide a novel understanding in the peptide-binding motifs of class I MHC molecules. (C) 2000 John Wiley and Sons, Inc.
UR - http://www.scopus.com/inward/record.url?scp=0034668132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034668132&partnerID=8YFLogxK
U2 - 10.1002/1097-0282(20001015)54:5<318::AID-BIP30>3.0.CO;2-T
DO - 10.1002/1097-0282(20001015)54:5<318::AID-BIP30>3.0.CO;2-T
M3 - Article
C2 - 10935972
AN - SCOPUS:0034668132
SN - 0006-3525
VL - 54
SP - 318
EP - 327
JO - Biopolymers
JF - Biopolymers
IS - 5
ER -